Skip to content
10-Q

Quarterly Report

Ovid Therapeutics Inc. OVID

0001636651-25-000012

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 71.21M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $49K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$27.93M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$45.95M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $20.61M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $26.3M
Stockholders Equity Q3 2025 · Sep 30, 2025 $44.7M
Stockholders Equity Q3 2025 · Jun 30, 2025 $55.79M
Stockholders Equity Q3 2025 · Mar 31, 2025 $59.28M
Stockholders Equity Q3 2025 · Dec 31, 2024 $68.23M
Stockholders Equity Q3 2025 · Sep 30, 2024 $76.29M
Stockholders Equity Q3 2025 · Jun 30, 2024 $88.9M
Stockholders Equity Q3 2025 · Mar 31, 2024 $78.28M
Stockholders Equity Q3 2025 · Dec 31, 2023 $87.8M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.8M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.52M
Total Liabilities Q3 2025 · Sep 30, 2025 $19.15M
Total Liabilities Q3 2025 · Dec 31, 2024 $23.94M
Current Assets Q3 2025 · Sep 30, 2025 $28.82M
Current Assets Q3 2025 · Dec 31, 2024 $55.94M
Total Assets Q3 2025 · Sep 30, 2025 $63.85M
Total Assets Q3 2025 · Dec 31, 2024 $92.17M
Rd Expense Q3 2025 · Sep 30, 2025 $5.87M
Rd Expense Q3 2025 · Sep 30, 2025 $18.99M
Rd Expense Q3 2025 · Sep 30, 2024 $7.86M
Rd Expense Q3 2025 · Sep 30, 2024 $30.84M
Net Income Q3 2025 · Sep 30, 2025 −$12.16M
Net Income Q3 2025 · Sep 30, 2025 −$27.08M
Net Income Q3 2025 · Jun 30, 2025 −$4.68M
Net Income Q3 2025 · Mar 31, 2025 −$10.24M
Net Income Q3 2025 · Sep 30, 2024 −$14.01M
Net Income Q3 2025 · Sep 30, 2024 −$17.18M
Net Income Q3 2025 · Jun 30, 2024 $8.52M
Net Income Q3 2025 · Mar 31, 2024 −$11.69M
Operating Income Q3 2025 · Sep 30, 2025 −$12.52M
Operating Income Q3 2025 · Sep 30, 2025 −$30.15M
Operating Income Q3 2025 · Sep 30, 2024 −$13.23M
Operating Income Q3 2025 · Sep 30, 2024 −$51.16M
Revenue Q3 2025 · Sep 30, 2025 $132K
Revenue Q3 2025 · Sep 30, 2025 $6.53M
Revenue Q3 2025 · Sep 30, 2024 $173K
Revenue Q3 2025 · Sep 30, 2024 $490K